PPARA and metabolic dysfunction-associated steatotic liver disease: These significantly downregulated mRNAs predominantly regulate pathways such as cholesterol metabolism, fat digestion and absorption, PPAR signaling, AMPK signaling, vitamin digestion and absorption, fatty acid metabolism, longevity, NAFLD, and insulin resistance (Figure 6b).